Dow-DuPont's $77 Billion Deal Wins EU Approval

The transcript discusses Du Pont's significant concessions to gain EU approval for a merger, including selling parts of its business. It highlights the impact on other industry mergers, such as Bayer-Monsanto and Syngenta-Chemchina, which are also under EU scrutiny. The text also covers EU-US antitrust relations, focusing on the challenges faced by EU Commissioner Vestager during her US visit amid leadership vacancies in US antitrust bodies.

What challenges does Margareta Vestager face during her visit to the US?

What implications might the EU's decisions have on US companies?